Citigroup »

Zentalis Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 146k 15.15
2023-09-30 $1.7M 85k 20.11
2023-03-31 $3.2M 189k 17.20
2022-12-31 $2.1M 102k 20.14
2022-09-30 $3.6M 169k 21.28
2021-12-31 $5.2M 62k 84.91
2021-03-31 $3.6M 82k 43.39
2020-12-31 $657k 12k 54.69
2020-09-30 $18k 565 31.86
2020-06-30 $68k 1.4k 48.36